|
DISCOVER |
III |
Friday, September 2, 2016 |
United States of America, Austria, United Kingdom, Denmark, Italy, Spain, Ireland, Germany, Canada, Netherlands |
MSM, Transgender women |
F/TAF, F/TDF |
Ongoing |
September 2021 |
|
Durbar (DMSC) and Ashodaya Samithi |
Demo Project |
Thursday, December 31, 2015 |
India |
Women |
|
Ongoing |
December 2016 |
|
East Bay Consortium/ CRUSH (Connecting Resources for Urban Sexual Health) |
Demo Project |
Wednesday, May 1, 2013 |
|
Women, Men, MSM |
|
Ongoing |
January 2017 |
|
EBONI |
IV |
Tuesday, August 23, 2022 |
|
Transgender women, Women |
Cabotegravir (GSK 744) |
Ongoing |
August 2024 |
|
ECLAIR |
II |
Monday, March 31, 2014 |
United States of America |
Men |
Cabotegravir (GSK 744), GSK 744 |
Completed |
March 2016 |
|
EMOTION - Enhancing Microbicide Uptake in High-Risk End Users |
Other |
Monday, July 4, 2016 |
Kenya, South Africa, Zimbabwe |
Women |
|
Ongoing |
July 2020 |
|
EMPOWER Consortium Demonstration Project |
Demo Project |
Thursday, September 1, 2016 |
South Africa, United Republic of Tanzania |
Women |
TDF/FTC (Truvada) |
Completed |
March 2018 |
|
Epi-PrEP |
Open Label |
Thursday, July 16, 2015 |
United States of America |
|
TDF/FTC (Truvada) |
Planned |
December 2017 |
|
EPIC NSW Trial - Expanded PrEP Implementation in Communities |
Demo Project |
Tuesday, March 1, 2016 |
Australia |
MSM |
|
Ongoing |
December 2017 |
|
Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents (CHAMPS Pilot Study B) |
II |
Wednesday, April 1, 2015 |
South Africa |
|
TDF/FTC (Truvada) |
Ongoing |
April 2017 |